Related Experiment Video
Updated: May 29, 2026

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
Published on: March 16, 2022
Two pathogenic mutations located within the 5'-regulatory sequence of the GJB1 gene affecting initiation of
Dagmara Kabzińska1, Katarzyna Kotruchow, Barbara Ryniewicz
1Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warszawa, Poland. dagkab@cmdik.pan.pl
Abstract:
In contrast to mutations in the coding sequences of a genes involved in the pathogenesis of Charcot-Marie-Tooth disease (CMT), little is known about CMT phenotypes resulting from a DNA variants located in regulatory sequences of a given " CMT gene". Charcot-Marie-Tooth type X1 disease (CMTX1) is caused by mutations in the GJB1 gene coding for an ion channel known as connexin, with a molecular mass of 32 kDa (Cx32). Only 0.01% of the GJB1 gene mutations have been reported in its 5' regulatory sequence. Pathogenic mutations occured in the internal ribosome entry site (IRES) are extremely rarely reported in human genetic disorders. To the best of our knowledge, in this study we report for the first time in an Eastern European population, two CMTX1 families in which two pathogenic mutations in the 5' regulatory sequence of the GJB1 gene (c.-529T>C and -459C>T) have been found. The two mutations identified in our study disturb the 5' UTR sequence in two different ways, by affecting the transcription factor SOX10 binding site (c.-529T>C) and by the disrupting IRES element of GJB1 gene (c.-459C>T). These regions are responsible for transcription (SOX10) and initiation of translation (IRES), respectively. On the basis of our findings that, in contrast to the most DNA sequence variants reported in untranslated regulatory regions of genes, the c.-459C>T and c.-529T>C mutations remain pathogenic in the context of different ethnic background.
Insights
This study identifies two novel pathogenic mutations in the GJB1 gene's regulatory sequence, causing Charcot-Marie-Tooth type X1 disease (CMTX1). These findings expand our understanding of CMTX1 genetics in Eastern European populations.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Charcot-Marie-Tooth disease (CMT) pathogenesis is primarily linked to coding gene mutations.
- Regulatory DNA variants in CMT genes are less understood.
- Charcot-Marie-Tooth type X1 (CMTX1) results from GJB1 gene mutations, encoding connexin 32 (Cx32).
Observation:
- Mutations in the 5' regulatory sequence of the GJB1 gene are rare.
- Pathogenic mutations within internal ribosome entry sites (IRES) are exceptionally uncommon in human disorders.
- This study reports two novel pathogenic mutations in the GJB1 5' regulatory sequence within an Eastern European population.
Findings:
- Two mutations, c.-529T>C and c.-459C>T, were identified in the GJB1 5' untranslated region (UTR).
- The c.-529T>C mutation disrupts the SOX10 transcription factor binding site, impacting gene transcription.
- The c.-459C>T mutation disrupts the GJB1 gene's IRES element, affecting translation initiation.
Implications:
- These findings highlight the pathogenic potential of regulatory GJB1 variants in CMTX1.
- The identified mutations are pathogenic across different ethnic backgrounds, suggesting broader clinical relevance.
- This research expands the known mutational spectrum for CMTX1 and emphasizes the importance of non-coding regulatory regions in genetic diseases.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Leaky Scanning
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations

